<DOC>
	<DOCNO>NCT01833117</DOCNO>
	<brief_summary>The purpose study compare effect FID 119515A Blink® Tears integrity tear film adult history dry eye eye .</brief_summary>
	<brief_title>Efficacy Safety Study FID 119515A</brief_title>
	<detailed_description>Subjects meet enrollment criterion randomize 2:1 manner receive treatment FID 119515A Blink® Tears respectively 1-day , single-dose study .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Sign Informed Consent . Best correct visual acuity ( BCVA ) 55 great eye measure ETDRS chart ( letter read method ) . At least 3 month document history dry eye eye . TBUT Ocular Surface Disease Index ( OSDI ) Questionnaire score specify protocol . Other protocoldefined inclusion criterion may apply . Pregnant breastfeeding . Any evidence ocular infection inflammation within 30 day prior Screening . Any ocular surgery . Ocular trauma require medical pharmacological treatment within 1 year Screening . Current presence punctal plug ( permanent temporary ) previous permanent punctal closure cautery/diathermy . Use topical ocular prescription nonprescription medication within 30 day Screening . Participation clinical trial within 30 day prior Screening . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Dry eye</keyword>
	<keyword>Tear film</keyword>
	<keyword>Tear break-up time</keyword>
	<keyword>Ocular surface</keyword>
	<keyword>Eye drop</keyword>
</DOC>